Associate Professor, Internal Medicine, Mayo Medical School
Cardiology
Dr. Barry A. Borlaug, MD
|
|
Give Review
Dr. Barry A. Borlaug is an expert in the field of Cardiology. He studied medicine at University of Wisconsin School of Medicine and Public Health. He received 1 awards: "Fellow (FACC)". Barry Borlaug is also published. He has 86 publications published. The lastest publication: "Defining HFpEF: where do we draw the line?' Barry Borlaug accepts Medicare payments and is registered with Medicare.gov.
Publications
- Defining HFpEF: where do we draw the line?
- Associations of Alterations in Pulsatile Arterial Load With Left Ventricular Longitudinal Strain.
- The interventional Heart failure initiative: A mission statement for the next generation of invasive cardiologists.
- Galectin-3 in Heart Failure With Preserved Ejection Fraction: A RELAX Trial Substudy (Phosphodiesterase-5 Inhibition to Improve Clinical Status and Exercise Capacity i...
- Exercise intolerance in Heart failure with preserved ejection fraction: what does the Heart have to do with it?
- Left atrial remodeling and function in advanced Heart failure with preserved or reduced ejection fraction.
- Nitrate's effect on activity tolerance in Heart failure with preserved ejection fraction trial: rationale and design.
- Exercise training as therapy for Heart failure: current status and future directions.
- Differential hemodynamic effects of exercise and volume expansion in people with and without Heart failure.
- Stage B Heart Failure: Is It More Common Than We Think?
- Impact of Chronic changes in arterial compliance and resistance on left ventricular ageing in humans.
- The Hemodynamic Basis of Exercise Intolerance in Tricuspid Regurgitation.
- Impact of General and Central Adiposity on Ventricular-Arterial Aging in Women and Men.
- Exercise haemodynamics and outcome in patients with dyspnoea.
- MY APPROACH to Heart Failure With Preserved Ejection Fraction.
- Invasive Hemodynamic Characterization of Heart Failure with Preserved Ejection Fraction.
- Heart failure with preserved ejection fraction: current understandings and challenges.
- Fatness, Fitness, Stiffness, and Age: How Does it Lead to Heart Failure?
- The sHunt for better breathing in Heart failure with preserved ejection fraction.
- The pathophysiology of Heart failure with preserved ejection fraction.
- Resting Ventricular-Vascular Function and Exercise Capacity in Heart Failure With Preserved Ejection Fraction: A RELAX Trial Ancillary Study.
- Right Heart dysfunction in Heart failure with preserved ejection fraction.
- Use of metformin in Diseases of aging.
- Implications of Coronary Artery Disease in Heart Failure with preserved Ejection Fraction.
- InterAtrial pressure gradients during simulated obstructive sleep apnea: A catheter-based study.
- A randomized pilot study of aortic waveform guided therapy in chronic Heart failure.
- Effects of an Interatrial Shunt on Rest and Exercise Hemodynamics: Results of a Computer Simulation in Heart Failure.
- Strain improves risk prediction beyond ejection fraction in chronic systolic Heart failure.
- Impact of atrial fibrillation on exercise capacity in Heart failure with preserved ejection fraction: a RELAX trial ancillary study.
- Invasive assessment of Pulmonary hypertension: time for a more fluid approach?
- Mechanisms of exercise intolerance in Heart failure with preserved ejection fraction.
- The cGMP signaling pathway as a therapeutic target in Heart failure with preserved ejection fraction.
- Acute effects of atrial fibrillation on atrial and ventricular function: A simultaneous invasive-echocardiographic hemodynamic study.
- Low-Dose Dopamine or Low-Dose Nesiritide in Acute Heart Failure With Renal Dysfunction: The ROSE Acute Heart Failure Randomized Trial.
- Longitudinal changes in left ventricular stiffness: a community-based study.
- Ventricular-arterial coupling, remodeling, and prognosis in chronic Heart failure.
- Sildenafil and exercise capacity in Heart failure--in reply.
- Clinical features, hemodynamics, and outcomes of pulmonary hypertension due to chronic Heart failure with reduced ejection fraction: pulmonary hypertension and Heart f...
- Invasive measures of afterload in low gradient severe Aortic stenosis with preserved ejection fraction.
- Heart Rate Reduction:It's not just for ventricles anymore.
- Relationships between Right Ventricular Function, Body Composition and Prognosis in Advanced Heart Failure.
- Resting Heart Rate and Heart Rate Reserve in Advanced Heart Failure Have Distinct Pathophysiologic Correlates and Prognostic Impact: A Prospective Pilot Study.
- Heart failure: Aldosterone antagonism for HFpEF.
- Heart failure with preserved and reduced ejection fraction: different risk profiles for different diseases.
- Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in Heart failure with preserved ejection fraction: a randomized clinical trial.
- Cardiac output response to exercise in relation to metabolic demand in Heart failure with preserved ejection fraction.
- Sex Differences in Arterial Stiffness and Ventricular-Arterial Interactions.
- Electrophysiological and hemodynamic characteristics associated with obesity in patients with Atrial fibrillation.
- Relationship between diastolic function and Heart rate recovery after symptom-limited exercise.
- Pulmonary Capillary Wedge Pressure Augments Right Ventricular Pulsatile Loading.
- Why are women more likely than men to develop Heart failure with preserved ejection fraction?
- Bedside Assessment of Cardiac Hemodynamics: The Impact of Noninvasive Testing and Examiner Experience.
- Diastolic and systolic Heart failure are distinct phenotypes within the Heart failure spectrum.
- Discerning Pulmonary venous from Pulmonary arterial hypertension without the help of a catheter.
- Diastolic relaxation and compliance reserve during dynamic exercise in Heart failure with preserved ejection fraction.
- Sex, load, and relaxation are women more susceptible to load-dependent diastolic dysfunction?
- "Carcinoid-like" tricuspid valvulopathy associated with nephrogenic systemic fibrosis.
- Global cardiovascular reserve dysfunction in Heart failure with preserved ejection fraction.
- Exercise hemodynamics enhance diagnosis of early Heart failure with preserved ejection fraction.
- Size, shape, and stamina: the impact of left ventricular geometry on exercise capacity.
- Heart Failure with Preserved Ejection Fraction: Pathophysiology and Emerging Therapies.
- Contractility and ventricular systolic stiffening in hypertensive Heart disease insights into the pathogenesis of Heart failure with preserved ejection fraction.
- Age-associated increases in pulmonary Artery systolic pressure in the general population.
- Invasive hemodynamic assessment in Heart failure.
- Pulmonary hypertension in Heart failure with preserved ejection fraction: a community-based study.
- Severe Heart failure in the setting of relatively mild mitral stenosis: the role of invasive hemodynamic assessment.
- Ventricular-vascular interaction in Heart failure.
- Beyond low-density lipoprotein cholesterol: defining the role of low-density lipoprotein heterogeneity in Coronary artery disease.
- Impact of arterial load and loading sequence on left ventricular tissue velocities in humans.
- Cardiac structure and ventricular-vascular function in persons with Heart failure and preserved ejection fraction from Olmsted County, Minnesota.
- Cardiovascular features of Heart failure with preserved ejection fraction versus nonfailing hypertensive left ventricular hypertrophy in the urban Baltimore community:...
- Impaired chronotropic and vasodilator reserves limit exercise capacity in patients with Heart failure and a preserved ejection fraction.
- Tricuspid annular displacement predicts survival in Pulmonary hypertension.
- Mechanisms of diastolic dysfunction in Heart failure.
- Sildenafil inhibits beta-adrenergic-stimulated cardiac contractility in humans.
- Age- and gender-related ventricular-vascular stiffening: a community-based study.
- Functional impact of rate irregularity in patients with Heart failure and atrial fibrillation receiving cardiac resynchronization therapy.
- Letter by forfia and borlaug regarding article, "pulmonary hypertension in Heart failure with preserved ejection fraction: a target of phosphodiesterase-5 inhibition i...
- Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment.
- Caveat medicus! Pulmonary hypertension in the elderly: a word of caution.
- The effect of loading alterations on left ventricular torsion: a simultaneous catheterization and two-dimensional speckle tracking echocardiographic study.
- Glycyrrhetinic acid attenuates vascular smooth muscle vasodilatory function in healthy humans.
- Differentiation of tricuspid regurgitation from constrictive pericarditis: novel criteria for diagnosis in the cardiac catheterisation laboratory.
- Stress hormone and circulating biomarker profile of apical ballooning Syndrome (Takotsubo cardiomyopathy): insights into the clinical significance of B-type natriureti...
- Estimation of central pressure augmentation using automated radial Artery tonometry.
Schools
University of Wisconsin Madison
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- View All
Conditions Treated
- Aneurysm and Dissection of Heart
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Dissection
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
Awards
- Fellow (FACC)
Education
-
Johns Hopkins University -
Brigham and Women's Hospital -
University of Wisconsin School of Medicine and Public Health
Hospital
-
Mayo Clinic - Rochester, Minnesota
Drug Facts
| NPI NUMBER | 1518975374 | |
| NPPES Provider LastName | BORLAUG | |
| NPPES Provider FirstName | BARRY | |
| NPPES Provider ZIPCode | 559050001 | |
| NPPES Provider State | MN | |
| Specialty Description | Cardiology | |
| Total Claim Count | 445.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1518975374 |
| Last Name Of The Provider | BORLAUG |
| First Name Of The Provider | BARRY |
| View All |
Similar Doctors
|
|
Dr. Chad J. Zack, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Raul E. Espinosa, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stephen L. Kopecky, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Omar F. Abou Ezzeddine, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Yong-Mei Cha, MD |
|
|
Dr. Anthony A. Hilliard, MD |
|
|
Dr. Panithaya Chareonthaitawee, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeremy J. Thaden, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thom W. Rooke, MD |
|
|
Dr. Lawrence J. Sinak, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Patricia J. Best, MD
This Doctor is OpenDoctor Recommended.
|